Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension

  Free Subscription


08.11.2021

1 Acta Cardiol
2 Am J Respir Crit Care Med
1 Arq Bras Cardiol
1 Best Pract Res Clin Rheumatol
1 Biol Pharm Bull
1 BMC Med Res Methodol
1 BMC Pulm Med
1 Can Vet J
1 Cardiol Young
1 Cells
1 Croat Med J
1 Drug Des Devel Ther
1 Eur Heart J
1 Eur Respir J
1 Hypertension
1 Int J Mol Sci
1 J Clin Invest
1 J Crit Care Med (Targu Mures)
1 J Korean Med Sci
1 JACC Cardiovasc Interv
1 Pulm Circ
1 Pulm Pharmacol Ther
1 Rev Esp Cardiol (Engl Ed)
1 SAGE Open Med
1 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Cardiol

  1. GHIO S, Fortuni F, Capettini AC, Scelsi L, et al
    Iron deficiency in pulmonary arterial hypertension: prevalence and potential usefulness of oral supplementation.
    Acta Cardiol. 2021;76:162-167.
    PubMed         Abstract available


    Am J Respir Crit Care Med

  2. SUN YY, Wang L, Liu JM, Yuan P, et al
    Reply to: circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2021 Nov 5. doi: 10.1164/rccm.202108-1905.
    PubMed        

  3. SUN X, Chen R, Yao X, Zheng Z, et al
    circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2021 Nov 5. doi: 10.1164/rccm.202108-1868.
    PubMed        


    Arq Bras Cardiol

  4. FERNANDES CJ, Calderaro D, Assad APL, Salibe-Filho W, et al
    Update on the Treatment of Pulmonary Arterial Hypertension.
    Arq Bras Cardiol. 2021;117:750-764.
    PubMed         Abstract available


    Best Pract Res Clin Rheumatol

  5. SAKETKOO LA, Frech T, Varju C, Domsic R, et al
    A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.
    Best Pract Res Clin Rheumatol. 2021;35:101707.
    PubMed         Abstract available


    Biol Pharm Bull

  6. IMANO H, Kato R, Nomura A, Tamura M, et al
    Rivaroxaban Attenuates Right Ventricular Remodeling in Rats with Pulmonary Arterial Hypertension.
    Biol Pharm Bull. 2021;44:669-677.
    PubMed         Abstract available


    BMC Med Res Methodol

  7. BIEDERMANN P, Ong R, Davydov A, Orlova A, et al
    Standardizing registry data to the OMOP Common Data Model: experience from three pulmonary hypertension databases.
    BMC Med Res Methodol. 2021;21:238.
    PubMed         Abstract available


    BMC Pulm Med

  8. STUBBE B, Seyfarth HJ, Kleymann J, Halank M, et al
    Monotherapy in patients with pulmonary arterial hypertension at four German PH centres.
    BMC Pulm Med. 2021;21:130.
    PubMed         Abstract available


    Can Vet J

  9. ROGG S, Thomason JD, Boyd N
    Unmasking of left heart dilation following treatment for precapillary pulmonary hypertension.
    Can Vet J. 2021;62:1177-1180.
    PubMed         Abstract available


    Cardiol Young

  10. LEI Y, Zhang X, Feng Y, Wang J, et al
    Risk factors of pulmonary arterial hypertension in patients with systemic lupus erythematosus.
    Cardiol Young. 2021;31:1619-1624.
    PubMed         Abstract available


    Cells

  11. DIERICK F, Solinc J, Bignard J, Soubrier F, et al
    Progenitor/Stem Cells in Vascular Remodeling during Pulmonary Arterial Hypertension.
    Cells. 2021;10.
    PubMed         Abstract available


    Croat Med J

  12. GASPAROVIC K, Pavlisa G, Hrabak Paar M, Brestovac M, et al
    Diagnostic accuracy, sensitivity, and specificity of CT pulmonary artery to aorta diameter ratio in screening for pulmonary hypertension in end-stage COPD patients.
    Croat Med J. 2021;62:446-445.
    PubMed         Abstract available


    Drug Des Devel Ther

  13. LIU P, Huang W, Ding Y, Wu J, et al
    Fasudil Dichloroacetate Alleviates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension by Ameliorating Dysfunction of Pulmonary Arterial Smooth Muscle Cells.
    Drug Des Devel Ther. 2021;15:1653-1666.
    PubMed         Abstract available


    Eur Heart J

  14. RUILOPE LM, Valenzuela PL, Lucia A
    Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?
    Eur Heart J. 2021 Sep 27. pii: 6377082. doi: 10.1093.
    PubMed        


    Eur Respir J

  15. BOUCLY A, Weatherald J, Savale L, de Groote P, et al
    External validation of a refined 4-strata risk assessment score from the French pulmonary hypertension Registry.
    Eur Respir J. 2021 Nov 4. pii: 13993003.02419-2021.
    PubMed         Abstract available


    Hypertension

  16. WANG S, Zhu G, Jiang D, Rhen J, et al
    Reduced Notch1 Cleavage Promotes the Development of Pulmonary Hypertension.
    Hypertension. 2021 Nov 5:HYPERTENSIONAHA12016065.
    PubMed         Abstract available


    Int J Mol Sci

  17. HSU CH, Liu IF, Kuo HF, Li CY, et al
    miR-29a-3p/THBS2 Axis Regulates PAH-Induced Cardiac Fibrosis.
    Int J Mol Sci. 2021;22.
    PubMed         Abstract available


    J Clin Invest

  18. SIMONS M
    Fibroblast growth factors: the keepers of endothelial normalcy.
    J Clin Invest. 2021;131.
    PubMed         Abstract available


    J Crit Care Med (Targu Mures)

  19. WOOD C, Balciunas M, Lordan J, Mellor A, et al
    Perioperative Management of Pulmonary Hypertension. a Review.
    J Crit Care Med (Targu Mures). 2021;7:83-96.
    PubMed         Abstract available


    J Korean Med Sci

  20. PARK JH, Bae JG, Chang YS
    Neonatal Outcomes according to the Latent Period from Membrane Rupture to Delivery among Extremely Preterm Infants Exposed to Preterm Premature Rupture of Membrane: a Nationwide Cohort Study.
    J Korean Med Sci. 2021;36:e93.
    PubMed         Abstract available


    JACC Cardiovasc Interv

  21. BRENER MI, Grayburn P, Lindenfeld J, Burkhoff D, et al
    Right Ventricular-Pulmonary Arterial Coupling in Patients With HF Secondary MR: Analysis From the COAPT Trial.
    JACC Cardiovasc Interv. 2021;14:2231-2242.
    PubMed         Abstract available


    Pulm Circ

  22. ISMAIL R, Hegab S, Kelly B, Franco-Palacios DJ, et al
    Serious illness conversations in pulmonary hypertension.
    Pulm Circ. 2021;11:20458940211037529.
    PubMed         Abstract available


    Pulm Pharmacol Ther

  23. ROSSI R, Talarico M, Schepis F, Coppi F, et al
    Effects of sildenafil on right ventricle remodelling in Portopulmonary hypertension.
    Pulm Pharmacol Ther. 2021;70:102071.
    PubMed         Abstract available


    Rev Esp Cardiol (Engl Ed)

  24. CRUZ-UTRILLA A, Gallego N, Segura de la Cal T, Tenorio-Castano J, et al
    The role of genetics in pulmonary arterial hypertension associated with congenital heart disease.
    Rev Esp Cardiol (Engl Ed). 2021;74:884-886.
    PubMed        


    SAGE Open Med

  25. KJELLSTROM B, Ivarsson B, Landenfelt Gestre LL, Ryftenius H, et al
    Respiratory rate modulation improves symptoms in patients with pulmonary hypertension.
    SAGE Open Med. 2021;9:20503121211053930.
    PubMed         Abstract available


    Transplantation

  26. CARTIN-CEBA R, Burger C, Swanson K, Vargas H, et al
    Clinical Outcomes after Liver Transplantation in Patients with Portopulmonary Hypertension.
    Transplantation. 2020 Oct 12. doi: 10.1097/TP.0000000000003490.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: